BDTX

BDTX

USD

Black Diamond Therapeutics Inc. Common Stock

$2.375+0.025 (1.064%)

Preço em tempo real

Healthcare
Biotecnologia
Estados Unidos

Gráfico de preços

Loading Chart...

Métricas-chave

Métricas de mercado
Fundamentos da empresa
Estatísticas de negociação

Métricas de mercado

Abertura

$2.350

Máximo

$2.380

Mínimo

$2.300

Volume

0.56M

Fundamentos da empresa

Capitalização de mercado

135.0M

Setor

Biotecnologia

País

United States

Estatísticas de negociação

Volume médio

3.50M

Bolsa de valores

NMS

Moeda

USD

Faixa de 52 semanas

Mínimo $1.195Atual $2.375Máximo $6.75

Notícias relacionadas

GlobeNewswire

Servier and Black Diamond Therapeutics Announce Global Licensing Agreement for BDTX-4933, A Targeted Oncology Therapy

The partnership underscores Servier's commitment to developing targeted therapies that address unmet medical needs in oncologyServier will develop and commercialize BDTX-4933, a Phase 1 asset with best-in-class potential

Ver mais
Servier and Black Diamond Therapeutics Announce Global Licensing Agreement for BDTX-4933, A Targeted Oncology Therapy
Analyst Upgrades

HC Wainwright & Co. Maintains Buy on Black Diamond Therapeutic, Raises Price Target to $12

HC Wainwright & Co. analyst Robert Burns maintains Black Diamond Therapeutic with a Buy and raises the price target from $11 to $12.

Ver mais
HC Wainwright & Co. Maintains Buy on Black Diamond Therapeutic, Raises Price Target to $12
Analyst Upgrades

Stifel Maintains Buy on Black Diamond Therapeutic, Lowers Price Target to $15

Stifel analyst Bradley Canino maintains Black Diamond Therapeutic with a Buy and lowers the price target from $16 to $15.

Ver mais
Stifel Maintains Buy on Black Diamond Therapeutic, Lowers Price Target to $15

Mantenha-se atualizado

Defina um alerta de preço, obtenha atualizações de análise de IA e notícias de mercado em tempo real.